President, COO and Secretary Peter Dritschilo resigns effective July 24, 2025

Shuttle Pharmaceuticals Holdings, Inc.

Peter Dritschilo resigned as President, Chief Operating Officer and Secretary on July 24, 2025.
No replacement has been named for the vacant positions.
Resignation effective immediately; Christopher Cooper remains Interim CEO.

item 5.02

Shuttle Pharmaceuticals Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-021566

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.